Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response
Related Experiment Video
Updated: Sep 10, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Di Fei Sun1, Yoshihide Fujigaki, Taiki Fujimoto
1First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Abstract:
We recently reported that transient appearance of interstitial myofibroblasts and infiltrating macrophages might play a role in cellular recovery in uranyl acetate (UA)-induced acute renal failure (ARF). Here we tested the effects of mycophenolate mofetil (MMF), which attenuates infiltration of lymphocytes, macrophages, and myofibroblasts, but does not suppress epithelial regeneration, on renal tissue repair. Rats treated with MMF (20 mg/kg/day) or vehicle were sacrificed at 2, 5, and 7 days after induction of ARF by injection of 5 mg/kg UA. Renal tissues were immunostained for bromodeoxyuridine (BrdU) and Ki67, alpha-smooth muscle actin (alpha-SMA), ED1, and CD43. The expression levels of alpha-SMA mRNA were examined by reverse transcription-polymerase chain reaction. Body weight loss or serum albumin levels were similar in MMF and vehicle rats during the experiment. In vehicle group, serum creatinine (Scr) significantly increased after day 5, but proximal tubular (PT) damage score increased as early as day 2 after UA injection. BrdU- or Ki67-positive regenerating tubular cells, ED1-positive macrophages and alpha-SMA-positive myofibroblasts significantly increased in the interstitium after day 5. In MMF-treated rats, Scr and PT damage score significantly increased at day 7 and the number of regenerating PT were significantly reduced compared with vehicle-treated rats at days 5 and 7. The numbers of macrophages and myofibroblasts and the expression of alpha-SMA mRNA were significantly lower in MMF than in vehicle rats at day 5, indicating that reduced interstitial cellular response is linked to the inhibition of regenerative repair. CD43-positive lymphocytes were significantly reduced in MMF group than in vehicle group at day 7, suggesting that lymphocyte infiltration does not seem to contribute to early regenerative response of proximal tubules. The transient appearance of myofibroblasts and macrophages in the interstitium may promote regenerative repair in UA-induced ARF in rats.
Insights
Mycophenolate mofetil (MMF) impaired renal tissue repair in acute renal failure by reducing myofibroblasts and macrophages. This suggests these cells are crucial for kidney recovery after injury.
Area of Science:
- Nephrology
- Cell Biology
- Immunology
Background:
- Acute renal failure (ARF) involves complex cellular responses.
- Interstitial myofibroblasts and macrophages are implicated in renal recovery.
- Uranyl acetate (UA) is a model toxin for inducing ARF.
Purpose of the Study:
- To investigate the role of mycophenolate mofetil (MMF) in renal tissue repair following UA-induced ARF.
- To determine if MMF, by modulating immune cell infiltration, affects kidney regeneration.
Main Methods:
- Rats with UA-induced ARF were treated with MMF or vehicle.
- Renal tissues were analyzed for cell proliferation (BrdU, Ki67), macrophages (ED1), myofibroblasts (alpha-SMA), and lymphocytes (CD43).
- Alpha-SMA mRNA expression and serum creatinine were assessed.
Main Results:
- MMF treatment reduced macrophages and myofibroblasts, correlating with impaired proximal tubule regeneration.
- Serum creatinine and tubular damage scores were higher in MMF-treated rats at later time points.
- Lymphocyte infiltration was reduced by MMF but did not appear to impact early regeneration.
Conclusions:
- Transient myofibroblasts and macrophages in the renal interstitium may promote regenerative repair in UA-induced ARF.
- MMF's inhibition of these cells hinders kidney tissue repair.
- Targeting interstitial cellular responses could be a therapeutic strategy for ARF.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

